Bright Peak Therapeutics Presents New Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Medigene to present first pre-clinical data for MDG1015

Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology

Theratechnologies to Present Preclinical Data at AACR

Data show that sudocetaxel zendusortide (TH1902) can induce tumor infiltrating lymphocytes and potentiate anti-PD-L1

Harpoon Therapeutics Announces Acceptance of Five Abstracts

Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine